Resonant mass measurement as an analytical tool
Predicting and measuring protein aggregation is a critical challenge in the formulation of biopharmaceuticals. This article describes an analytical tool that hits the ‘sweet spot’ of protein aggregation measurement
As work on biological molecules accounts for an increasing proportion of R&D expenditure in drug discovery and development, analytical testing is under the spotlight in the rapidly expanding biopharmaceutical sector. Not only is the cost of developing these molecules very high, this heavily regulated industry also constantly demands more appropriate and rigorous analytical measurements. Many in the sector have cited analytical bottlenecks as a major cause for concern and likely to constrain drug development.
